Your browser doesn't support javascript.
loading
Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score.
Jeffery, Hannah C; McDowell, Patrick; Lutz, Philipp; Wawman, Rebecca E; Roberts, Sheree; Bagnall, Chris; Birtwistle, Jane; Adams, David H; Oo, Ye Htun.
Afiliação
  • Jeffery HC; Centre for Liver Research and National Institute for Health Research Birmingham Biomedical Research Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • McDowell P; Centre for Liver Research and National Institute for Health Research Birmingham Biomedical Research Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Lutz P; Centre for Liver Research and National Institute for Health Research Birmingham Biomedical Research Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Wawman RE; Department of Internal Medicine I, University of Bonn, Bonn, Germany.
  • Roberts S; Centre for Liver Research and National Institute for Health Research Birmingham Biomedical Research Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Bagnall C; School of Life Sciences, Faculty of Health and Life Sciences, Coventry University, Coventry, United Kingdom.
  • Birtwistle J; Centre for Liver Research and National Institute for Health Research Birmingham Biomedical Research Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
  • Adams DH; Human Biomaterial Resource Centre, University of Birmingham, Birmingham, United Kingdom.
  • Oo YH; Clinical Immunology Department, University of Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
PLoS One ; 12(12): e0188649, 2017.
Article em En | MEDLINE | ID: mdl-29261670

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Linfócitos / Interleucina-13 / Doença Hepática Terminal / Anfirregulina / Imunidade Inata / Fígado / Modelos Biológicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Linfócitos / Interleucina-13 / Doença Hepática Terminal / Anfirregulina / Imunidade Inata / Fígado / Modelos Biológicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido